Investing

These Were The Five Best And Worst Performing Mid-Cap Stocks In Q3 2022

Svyatoslav Balan / iStock via Getty Images

Mid-cap companies are those that fall between small and large cap companies. Thus, they are more stable than small-cap companies and, at the same time, offer higher growth opportunities than large-cap companies.

Many investors view mid-cap stocks as a key portfolio diversification tool because of their ability to offer a balance between growth and stability. Let’s take a look at the five best and worst performing mid-cap stocks in Q3 2022.

Five Best Performing Mid-Cap Stocks In Q3 2022

We have taken the third-quarter return data of mid-cap stocks from finviz.com to develop this list of the five best and worst performing mid-cap stocks in Q3 2022. Here are the five best performing mid-cap stocks in Q3 2022:

  1. Signify Health (96%)

Founded in 2009 and headquartered in Norwalk, Conn., this company uses advanced analytics, technology and healthcare provider networks to come up with value-based payment programs. Signify Health Inc (NYSE:SGFY) shares are up by almost 106% year to date and up almost 1% in the last month.

As of this writing, Signify Health shares are trading above $29 with a 52-week range of $10.70 to $29.88, giving the company a market capitalization of more than $6.80 billion.

  1. Prometheus Biosciences (106%)

Founded in 2016 and headquartered in San Diego, this company focuses on developing novel precision therapeutics and companion diagnostics. Prometheus Biosciences Inc (NASDAQ:RXDX) shares are up by over 25% year to date but are down by over 2% in the last month.

As of this writing, Prometheus Biosciences shares are trading above $49 with a 52-week range of $21.50 to $63.13, giving the company a market capitalization of more than $2 billion.

  1. 1Life Healthcare (107%)

Founded in 2002 and headquartered in San Francisco, CA, this company provides healthcare membership services, including walk-in immunizations and lab services, sports medicine, lifestyle and more. 1life Healthcare Inc (NASDAQ:ONEM) shares are down by almost 3% year to date and down almost 1% in the last month.

As of this writing, 1Life Healthcare shares are trading above $17 with a 52-week range of $5.94 to $24.59, giving the company a market cap of more than $3.30 billion.

  1. Enovix (110%)

Founded in 2006 and headquartered in Fremont, Calif., this company designs and develops silicon-anode lithium-ion batteries. Enovix Corp (NASDAQ:ENVX) shares are down by almost 40% year to date and down over 11% in the last month.

As of this writing, Enovix shares are trading above $16 with a 52-week range of $7.26 to $39.48, giving the company a market capitalization of more than $2.50 billion.

  1. Verve Therapeutics (120%)

Founded in 2018 and headquartered in Cambridge, Mass., it is a genetic medicines company that develops new ways to treat cardiovascular disease. Verve Therapeutics Inc (NASDAQ:VERV) shares are down by over 13% year to date and down almost 9% in the last month.

As of this writing, Verve Therapeutics shares are trading above $31 with a 52-week range of $10.70 to $56.18, giving the company a market capitalization of more than $1.90 billion.

Five Worst Performing Mid-Cap Stocks In Q3 2022

These were the five worst performing mid-cap stocks in Q3 2022:

  1. Neogen (-43%)

Founded in 1981 and headquartered in Lansing, Mich., this company develops, makes, and sells food and animal safety products. NeoGenomics, Inc. (NASDAQ:NEO) shares are down by almost 76% year to date and down over 25% in the last month.

As of this writing, Neogen shares are trading above $11 with a 52-week range of $10.49 to $47.80, giving the company a market capitalization of more than $2.30 billion.

  1. Applovin (-44%)

Founded in 2011 and headquartered in Palo Alto, Calif., this company develops and operates a mobile marketing platform. Applovin Corp (NASDAQ:APP) shares are down by over 81% year to date and down over 13% in the last month.

As of this writing, Applovin shares are trading above $17 with a 52-week range of $16.47 to $116.09, giving the company a market capitalization of more than $6.40 billion.

  1. WeWork (-47%)

Founded in 2010 and headquartered in New York City, this company offers flexible workspace solutions, including office spaces, internet connection, and other shared facilities. Wework Inc (NYSE:WE) shares are down by almost 76% year to date and down over 33% in the last month.

As of this writing, WeWork shares are trading above $2 with a 52-week range of $1.94 to $14.39, giving the company a market cap of more than $1.50 billion.

  1. Scotts Miracle-Gro (-47%)

Founded in 1868 and headquartered in Marysville, Ohio, this company makes and sells products for lawn and garden care and indoor and hydroponic gardening. Scotts Miracle-Gro Co (NYSE:SMG) shares are down by over 72% year to date and down almost 11% in the last month.

As of this writing, Scotts Miracle-Gro shares are trading above $45 with a 52-week range of $39.06 to $180.43, giving the company a market capitalization of more than $2.40 billion.

  1. Sotera Health (-65%)

Founded in 1978 and headquartered in Broadview Heights, Ohio, this company provides sterilization, lab testing and advisory services to medical devices and pharmaceutical companies. Sotera Health Co (NASDAQ:SHC) shares are down by over 72% year to date and down over 10% in the last month.

As of this writing, Sotera Health shares are trading above $6.90 with a 52-week range of $6.42 to $27.38, giving the company a market capitalization of more than $1.80 billion.

This article originally appeared on ValueWalk

Get Ready To Retire (Sponsored)

Start by taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes, or less.

Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.

Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future

Get started right here.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.